177 related articles for article (PubMed ID: 28103701)
1. Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients.
Lerner MZ; Mor N; Paek H; Blitzer A; Strome M
Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):340-343. PubMed ID: 28103701
[TBL] [Abstract][Full Text] [Related]
2. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the neck in patients with squamous cell carcinoma of the head and neck.
Jesse RH; Fletcher GH
Cancer; 1977 Feb; 39(2 Suppl):868-72. PubMed ID: 837350
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus, metformin and head and neck cancer.
Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
[TBL] [Abstract][Full Text] [Related]
7. Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY
Oncologist; 2015 May; 20(5):546-53. PubMed ID: 25802404
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy for cancer of the head and neck.
Donaldson RC
Am J Surg; 1973 Oct; 126(4):507-12. PubMed ID: 4743834
[No Abstract] [Full Text] [Related]
9. Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation.
Friedman M; DeNarvaes FN; Daly JF
Cancer; 1970 Sep; 26(3):711-21. PubMed ID: 5458276
[No Abstract] [Full Text] [Related]
10. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
12. Management of recurrent head and neck cancer.
Krespi YP; Wurster CF; Sisson GA
Otolaryngol Clin North Am; 1985 Aug; 18(3):613-9. PubMed ID: 4047677
[TBL] [Abstract][Full Text] [Related]
13. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of patients with squamous cell carcinoma of the upper respiratory and digestive tracts with no evidence of disease 5 years after initial treatment.
Kogelnik HD; Fletcher GH; Jesse RH
Radiology; 1975 May; 115(2):423-7. PubMed ID: 1144760
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
16. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
17. Contralateral neck failure in lateralized oral squamous cell carcinoma.
Habib M; Murgasen J; Gao K; Ashford B; Shannon K; Ebrahimi A; Clark JR
ANZ J Surg; 2016 Mar; 86(3):188-92. PubMed ID: 26138827
[TBL] [Abstract][Full Text] [Related]
18. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
19. [Cervical lymph node metastases of cancer of unknown location].
Vagner RI; Valdina EA; Mushkovskaia IuI
Vopr Onkol; 1972; 18(2):9-13. PubMed ID: 5012927
[No Abstract] [Full Text] [Related]
20. Current treatment of head and neck squamous cell cancer.
Belcher R; Hayes K; Fedewa S; Chen AY
J Surg Oncol; 2014 Oct; 110(5):551-74. PubMed ID: 25053506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
